These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 18056677)

  • 1. Protein biomarker identification in the CSF of patients with CNS lymphoma.
    Roy S; Josephson SA; Fridlyand J; Karch J; Kadoch C; Karrim J; Damon L; Treseler P; Kunwar S; Shuman MA; Jones T; Becker CH; Schulman H; Rubenstein JL
    J Clin Oncol; 2008 Jan; 26(1):96-105. PubMed ID: 18056677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Set of 17 microRNAs Common for Brain and Cerebrospinal Fluid Differentiates Primary Central Nervous System Lymphoma from Non-Malignant Brain Tumors.
    Sromek M; Rymkiewicz G; Paziewska A; Szafron LM; Kulecka M; Zajdel M; Kulinczak M; Dabrowska M; Balabas A; Bystydzienski Z; Chechlinska M; Siwicki JK
    Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies.
    Kersten MJ; Evers LM; Dellemijn PL; van den Berg H; Portegies P; Hintzen RQ; van Lier RA; von dem Borne AE; van Oers RH
    Blood; 1996 Mar; 87(5):1985-9. PubMed ID: 8634448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytologic findings in the cerebrospinal fluid in malignant lymphomas of the central nervous system].
    Jellinger K; Wrchovszky A
    Wien Klin Wochenschr; 1973 Jul; 85(29):522-5. PubMed ID: 4579372
    [No Abstract]   [Full Text] [Related]  

  • 5. MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study.
    Ferreri AJM; Calimeri T; Lopedote P; Francaviglia I; Daverio R; Iacona C; Belloni C; Steffanoni S; Gulino A; Anghileri E; Diffidenti A; Finardi A; Gagliardi F; Anzalone N; Nonis A; Furlan R; De Lorenzo D; Terreni MR; Martinelli V; Sassone M; Foppoli M; Angelillo P; Guggiari E; Falini A; Mortini P; Filippi M; Tarantino V; Eoli M; Ciceri F; Doglioni C; Tripodo C; Locatelli M; Cangi MG; Ponzoni M
    Br J Haematol; 2021 May; 193(3):497-505. PubMed ID: 33620087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of Central Nervous System (CNS) Involvement in Children With Non-Hodgkin's Lymphoma (NHL) and the Diagnostic Value of CSF Flow Cytometry in CNS Positive Disease.
    Huang S; Jin L; Yang J; Duan Y; Zhang M; Zhou C; Zhang YH
    Technol Cancer Res Treat; 2021; 20():15330338211016372. PubMed ID: 34060372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignancies.
    Schmid D; Warnken U; Latzer P; Hoffmann DC; Roth J; Kutschmann S; Jaschonek H; Rübmann P; Foltyn M; Vollmuth P; Winkler F; Seliger C; Felix M; Sahm F; Haas J; Reuss D; Bendszus M; Wildemann B; von Deimling A; Wick W; Kessler T
    J Neurochem; 2021 Jul; 158(2):522-538. PubMed ID: 33735443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis of cerebrospinal fluid from children with central nervous system tumors identifies candidate proteins relating to tumor metastatic spread.
    Spreafico F; Bongarzone I; Pizzamiglio S; Magni R; Taverna E; De Bortoli M; Ciniselli CM; Barzanò E; Biassoni V; Luchini A; Liotta LA; Zhou W; Signore M; Verderio P; Massimino M
    Oncotarget; 2017 Jul; 8(28):46177-46190. PubMed ID: 28526811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-30c as a novel diagnostic biomarker for primary and secondary B-cell lymphoma of the CNS.
    Baraniskin A; Chomiak M; Ahle G; Gress T; Buchholz M; Turewicz M; Eisenacher M; Margold M; Schlegel U; Schmiegel W; Hahn S; Schroers R
    J Neurooncol; 2018 May; 137(3):463-468. PubMed ID: 29327175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF analysis for protein biomarker identification in patients with leptomeningeal metastases from CNS lymphoma.
    Galicia N; Dégano R; Díez P; González-González M; Góngora R; Ibarrola N; Fuentes M
    Expert Rev Proteomics; 2017 Apr; 14(4):363-372. PubMed ID: 28293970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid beta-2-microglobulin in adult patients with acute leukemia or lymphoma: a useful marker in early diagnosis and monitoring of CNS-involvement.
    Hansen PB; Kjeldsen L; Dalhoff K; Olesen B
    Acta Neurol Scand; 1992 Mar; 85(3):224-7. PubMed ID: 1575009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma.
    Rubenstein JL; Wong VS; Kadoch C; Gao HX; Barajas R; Chen L; Josephson SA; Scott B; Douglas V; Maiti M; Kaplan LD; Treseler PA; Cha S; Hwang JH; Cinque P; Cyster JG; Lowell C
    Blood; 2013 Jun; 121(23):4740-8. PubMed ID: 23570798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin III is probably not a suitable biomarker for diagnosis of primary central nervous system lymphoma.
    Kuusisto ME; Haapasaari KM; Remes AM; Bloigu R; Karihtala P; Turpeenniemi-Hujanen T; Kuittinen O
    Ann Hematol; 2015 Jul; 94(7):1167-74. PubMed ID: 25697593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble TACI and soluble BCMA as biomarkers in primary central nervous system lymphoma.
    Thaler FS; Laurent SA; Huber M; Mulazzani M; Dreyling M; Ködel U; Kümpfel T; Straube A; Meinl E; von Baumgarten L
    Neuro Oncol; 2017 Nov; 19(12):1618-1627. PubMed ID: 28521029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL).
    Sasayama T; Nakamizo S; Nishihara M; Kawamura A; Tanaka H; Mizukawa K; Miyake S; Taniguchi M; Hosoda K; Kohmura E
    Neuro Oncol; 2012 Mar; 14(3):368-80. PubMed ID: 22156547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of central nervous system involvement in patients with leukemia or non-Hodgkin's lymphoma by immunological marker analysis of cerebrospinal fluid cells.
    Hooijkaas H; Adriaansen HJ; van Dongen JJ
    Cancer Treat Res; 1988; 38():149-71. PubMed ID: 2908594
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnostic value of interleukin-10 in cerebrospinal fluid for diffuse large B-cell lymphoma of the central nervous system.
    Sasagawa Y; Akai T; Tachibana O; Iizuka H
    J Neurooncol; 2015 Jan; 121(1):177-83. PubMed ID: 25258254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Combined Performance of ADC, CSF CXC Chemokine Ligand 13, and CSF Interleukin 10 in the Diagnosis of Central Nervous System Lymphoma.
    Mabray MC; Barajas RF; Villanueva-Meyer JE; Zhang CA; Valles FE; Rubenstein JL; Cha S
    AJNR Am J Neuroradiol; 2016 Jan; 37(1):74-9. PubMed ID: 26381553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of lymphoma, leukemia, and metastatic tumor involvement of the cerebrospinal fluid by cytology and immunocytochemistry.
    Tani E; Costa I; Svedmyr E; Skoog L
    Diagn Cytopathol; 1995 Feb; 12(1):14-22. PubMed ID: 7789240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphomas of the breast. A clinicopathologic and immunohistochemical study of primary and secondary cases.
    Cohen PL; Brooks JJ
    Cancer; 1991 Mar; 67(5):1359-69. PubMed ID: 1991299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.